ABN Amro Investment Solutions Takes $1.91 Million Position in Axon Enterprise, Inc $AXON

ABN Amro Investment Solutions bought a new position in Axon Enterprise, Inc (NASDAQ:AXON) in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm bought 2,658 shares of the biotechnology company’s stock, valued at approximately $1,907,000.

Several other large investors have also recently bought and sold shares of the business. Westside Investment Management Inc. boosted its position in Axon Enterprise by 4.8% during the 2nd quarter. Westside Investment Management Inc. now owns 283 shares of the biotechnology company’s stock worth $225,000 after acquiring an additional 13 shares during the period. CVA Family Office LLC boosted its holdings in shares of Axon Enterprise by 26.9% during the second quarter. CVA Family Office LLC now owns 66 shares of the biotechnology company’s stock worth $55,000 after purchasing an additional 14 shares during the period. Newbridge Financial Services Group Inc. grew its position in Axon Enterprise by 2.8% during the second quarter. Newbridge Financial Services Group Inc. now owns 508 shares of the biotechnology company’s stock valued at $421,000 after purchasing an additional 14 shares in the last quarter. Vicus Capital grew its position in Axon Enterprise by 3.7% during the third quarter. Vicus Capital now owns 396 shares of the biotechnology company’s stock valued at $284,000 after purchasing an additional 14 shares in the last quarter. Finally, Evergreen Capital Management LLC increased its stake in Axon Enterprise by 3.8% in the 2nd quarter. Evergreen Capital Management LLC now owns 413 shares of the biotechnology company’s stock valued at $342,000 after buying an additional 15 shares during the period. 79.08% of the stock is owned by institutional investors and hedge funds.

Insider Transactions at Axon Enterprise

In other news, President Joshua Isner sold 20,000 shares of Axon Enterprise stock in a transaction dated Monday, December 8th. The stock was sold at an average price of $552.60, for a total value of $11,052,000.00. Following the transaction, the president directly owned 249,502 shares in the company, valued at approximately $137,874,805.20. The trade was a 7.42% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CAO Jennifer H. Mak sold 1,134 shares of the stock in a transaction that occurred on Friday, December 19th. The shares were sold at an average price of $600.00, for a total value of $680,400.00. Following the sale, the chief accounting officer owned 13,740 shares of the company’s stock, valued at approximately $8,244,000. The trade was a 7.62% decrease in their position. The SEC filing for this sale provides additional information. Over the last ninety days, insiders have sold 48,040 shares of company stock worth $27,249,338. Corporate insiders own 5.70% of the company’s stock.

Axon Enterprise Trading Down 1.4%

Shares of AXON stock opened at $429.67 on Tuesday. Axon Enterprise, Inc has a 12 month low of $396.41 and a 12 month high of $885.91. The company has a market cap of $33.91 billion, a PE ratio of 135.97, a price-to-earnings-growth ratio of 12.94 and a beta of 1.48. The company has a quick ratio of 2.89, a current ratio of 3.12 and a debt-to-equity ratio of 0.57. The business’s 50 day moving average is $555.10 and its two-hundred day moving average is $645.15.

Wall Street Analysts Forecast Growth

Several equities analysts have recently commented on AXON shares. Morgan Stanley lowered their price target on shares of Axon Enterprise from $760.00 to $713.00 and set an “overweight” rating on the stock in a report on Wednesday, December 17th. Northcoast Research raised Axon Enterprise from a “neutral” rating to a “buy” rating and set a $742.00 price target for the company in a research note on Tuesday, January 6th. TD Cowen reiterated a “buy” rating on shares of Axon Enterprise in a report on Wednesday, November 5th. Royal Bank Of Canada began coverage on Axon Enterprise in a report on Monday, November 17th. They issued an “outperform” rating and a $860.00 price objective on the stock. Finally, Weiss Ratings reiterated a “hold (c-)” rating on shares of Axon Enterprise in a research note on Monday, December 29th. Fifteen research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, Axon Enterprise presently has an average rating of “Moderate Buy” and a consensus target price of $805.71.

About Axon Enterprise

Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company’s hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.

Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.